These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 1591301)
61. [Use of recombinant hematopoietic growth factors in autologous bone marrow transplantation and peripheral blood stem cell transplantation]. Hołowiecki J Acta Haematol Pol; 1994; 25(2 Suppl 1):95-103. PubMed ID: 8067214 [TBL] [Abstract][Full Text] [Related]
62. Spermine dialdehyde, a novel ex vivo purging agent for both allogenic and autologous bone marrow transplantations. Lau C; Wang E; Ishaque A; Jones K; Wong B; Kimsto L; Conant J Int J Immunopharmacol; 1992 Aug; 14(6):1081-91. PubMed ID: 1428363 [TBL] [Abstract][Full Text] [Related]
63. Treatment of multiple myeloma. San Miguel JF; Bladé Creixenti J; García-Sanz R Haematologica; 1999 Jan; 84(1):36-58. PubMed ID: 10091392 [TBL] [Abstract][Full Text] [Related]
64. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation. Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448 [TBL] [Abstract][Full Text] [Related]
65. PCR-positivity in harvested bone marrow predicts relapse after transplantation with autologous purged bone marrow in children in second remission of precursor B-cell acute leukaemia. Vervoordeldonk SF; Merle PA; Behrendt H; Steenbergen EJ; van den Berg H; van Wering ER; von dem Borne AE; van der Schoot CE; van Leeuwen EF; Slaper-Cortenbach IC Br J Haematol; 1997 Feb; 96(2):395-402. PubMed ID: 9029032 [TBL] [Abstract][Full Text] [Related]
66. Overview of autologous stem cell transplantation. Saba N; Abraham R; Keating A Crit Rev Oncol Hematol; 2000 Oct; 36(1):27-48. PubMed ID: 10996521 [TBL] [Abstract][Full Text] [Related]
67. Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction. Atta J; Fauth F; Keyser M; Petershofen E; Weber C; Lippok G; Hoelzer D; Martin H Bone Marrow Transplant; 2000 Jan; 25(1):97-104. PubMed ID: 10654022 [TBL] [Abstract][Full Text] [Related]
68. G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: parameters affecting bone marrow engraftment. Bolwell BJ; Fishleder A; Andresen SW; Lichtin AE; Koo A; Yanssens T; Burwell R; Baucco P; Green R Bone Marrow Transplant; 1993 Dec; 12(6):609-14. PubMed ID: 7511016 [TBL] [Abstract][Full Text] [Related]
69. Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: a case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma Registry. Williams CD; Goldstone AH; Pearce RM; Philip T; Hartmann O; Colombat P; Santini G; Foulard L; Gorin NC J Clin Oncol; 1996 Sep; 14(9):2454-64. PubMed ID: 8823323 [TBL] [Abstract][Full Text] [Related]
70. Normal hematopoietic reconstitution following ASTA-Z 7557-purged grafts in the absence of in vitro CFU-GM colony growth. Nagler A; Mumcuoglu M; Naparstek E; Or R; Gan S; Slavin S Leuk Res; 1993 Jan; 17(1):61-7. PubMed ID: 8429681 [TBL] [Abstract][Full Text] [Related]
71. Is bone marrow purging proving to be of value? Gulati SC; Romero CE; Ciavarella D Oncology (Williston Park); 1994 Sep; 8(9):19-24; discussion 24, 29-32. PubMed ID: 7993723 [TBL] [Abstract][Full Text] [Related]
72. [G-CSF - primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children]. Styczyński J; Debski R; Krenska A; Wysocki M Med Wieku Rozwoj; 2008; 12(4 Pt 2):1112-6. PubMed ID: 19531818 [TBL] [Abstract][Full Text] [Related]
73. Developments in purging in autotransplantation. Freedman AS; Nadler LM Hematol Oncol Clin North Am; 1993 Jun; 7(3):687-715. PubMed ID: 8344886 [TBL] [Abstract][Full Text] [Related]
74. Immunologically based methods for the elimination of tumor cells from autologous stem cell grafts. Gee AP Immunomethods; 1994 Dec; 5(3):232-42. PubMed ID: 7780690 [TBL] [Abstract][Full Text] [Related]
75. Importance of cellular defense mechanisms in the photodynamic purging of autologous bone marrow grafts. Sieber F; Gaffney DK; Yamazaki T; Qiu K Prog Clin Biol Res; 1994; 389():147-54. PubMed ID: 7700897 [No Abstract] [Full Text] [Related]
76. Purging of autografts: methods and clinical significance. Kvalheim G Ann Med; 1996 Apr; 28(2):167-73. PubMed ID: 8732646 [TBL] [Abstract][Full Text] [Related]
77. The role and methodology for purging tumor from autologous bone marrow and peripheral blood progenitor cells. Purdy MH; Shpall EJ Med Oncol; 1994; 11(2):47-51. PubMed ID: 7531586 [No Abstract] [Full Text] [Related]
78. Biological aspects and clinical results of autologous bone marrow transplantation for acute myeloid leukemia. Rizzoli V; Mangoni L; Carlo-Stella C Int J Clin Lab Res; 1992; 22(4):185-9. PubMed ID: 1467534 [TBL] [Abstract][Full Text] [Related]
79. The use of soybean agglutinin (SBA) for bone marrow (BM) purging and hematopoietic progenitor cell enrichment in clinical bone-marrow transplantation. Nagler A; Morecki S; Slavin S Mol Biotechnol; 1999 Apr; 11(2):181-94. PubMed ID: 10464772 [TBL] [Abstract][Full Text] [Related]
80. Polyclonal reconstitution of human marrow after allogeneic bone marrow transplantation. Nash R; Storb R; Neiman P Blood; 1988 Dec; 72(6):2031-7. PubMed ID: 2904291 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]